Disorders of Haemostasis COPY Flashcards

(42 cards)

1
Q

Give examples of minor bleeding symptoms

A
Easy bruising
Gum bleeding
Frequent nosebleeds
Bleeding after tooth extraction 
Post-operative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give examples of minor bleeding symptoms in women

A

Menorrhagia
Post-partum bleeding
Family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the elements of a significant bleeding history

A

Epistaxis not stopped by 10 minutes compression pr requiring medical attention/transfusion
Cutaneous haemorrhage or bruising with no trauma
Prolonged (>15min) bleeding from trivial wounds
Menorrhagia requiring treatment that leads to anaemia
Heavy, prolonged or recurrent bleeding after surgery or dental extraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why might abnormal haemostasis occur

A

Lack of a specific factor
Failure of production (congenital and acquired) or increased consumption/clearance

Defective function of a specific factor
Genetic defect or acquire defect (drugs, synthetic defect, inhibition)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give examples of disorders of primary haemostasis due to platelets

A

Low numbers - thrombocytopenia
Bone marrow failure e.g. leukaemia, B12 deficiency
Accelerated clearance e.g. immune (ITP), DIC

Impaired function
Hereditary absence of glycoproteins or storage granules
Acquired due to drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe auto-immune thrombocytopenic purpura

A
  1. Antiplatelet antibodies bind to a sensitised platelet
  2. Sensitised platelet binds to a macrophage via antibodies

Very common cause of thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the mechanisms and causes of thrombocytopenia

A
  1. Failure of platelet production by megakaryocytes
  2. Shortened half life of platelets
  3. Increased pooling of platelets in an enlarged spleen
    (hypersplenism) + shortened half life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give examples of hereditary platelet defects

A

Glanzmann’s thrombasthenia
Bernard Soulier syndrome
Storage Pool disease

No GPIIb/IIIa or GpIb or dense granules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which drugs may cause one to acquire impaired function of platelets

A

Aspirin
NSAIDs
Clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the functions of VWF in haemostasis

A

Binding to collagen and capturing platelets

Stabilising factor VIII (may be low if VWF is low)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the cause of VWF disease

A

Hereditary - deficiency of VWF (Type 1 or 3) or VWF with abnormal function (type 2)

Acquired due to antibody (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give examples of primary haemostasis disorders involving the vessel wall

A

Inherited (rare) - Hereditary haemorrhagic telangiectasia Ehlers-Danlos syndrome and other connective tissue disorders

Acquired - Scurvy, steroid therapy, ageing (senile purpura), vasculitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the typical bleeding of primary haemostasis

A
Immediate 
Prolonged bleeding from cuts
Epistaxes
Gum bleeding
Menorrhagia 
Easy bruising
Prolonged bleeding after trauma or surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What might be the typical bleeding specific to thrombocytopenia and severe VWD

A

thrombocytopenia - petechiae

Severe VWD - haemophilia-like bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the tests done for disorders of primary haemostasis

A

Platelet count, platelet morphology
Bleeding time (PFA100 in lab)
Assays of von Willebrand Factor
Clinical observation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which clotting factors are not serine proteases

A

V - co-factor
VIII - co-factor
XIII - transglutamidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which factors require post-transitional vit K dependent modification

18
Q

Describe the concentration-time graph for thrombin generation

A

After a TF trigger there is a surge in thrombin which then quickly decreases
Haemophilia - very small and slow peak (when thrombin is lowest)

19
Q

Describe haemophilia

A

Failure to generate fibrin to stabilise platelet plug
Deficiency in factor VIII/IX
Sex-linked recessive

20
Q

Describe the different bleeding in coagulation factor deficiencies (FVIII, IX, II, XI, XII)

A

VIII/IX - severe but compatible with life, spontaneous joint and muscle bleeding

Prothrombin - lethal

XI - bleed after trauma, not spontaneous

XII - no excess bleeding

21
Q

What are some acquired disorders of coagulation

A

Liver disease
Dilution
Anticoagulant drugs – warfarin

22
Q

How does liver failure lead to a coagulation disorder

A

Most coagulation factors are synthesised in the lvier

23
Q

Describe coagulation disorders due to dilution

A

Red cell transfusions no longer contain plasma

Major transfusions require plasma as well as rbc and platelets

24
Q

What are the causes of increased consumption

A

Acquired
Disseminated intravascular coagulation (DIC)
Immune - autoantibodies

25
Describe disseminated intravascular coagulation
Generalised activation of coagulation – Tissue factor Associated with sepsis, major tissue damage, inflammation Consumes and depletes coagulation factors Platelets consumed Activation of fibrinolysis depletes fibrinogen Deposition of fibrin in vessels causes organ failure
26
Describe the typical bleeding in coagulation disorders (Secondary)
superficial cuts do not bleed (platelets) bruising is common, nosebleeds are rare spontaneous bleeding is deep, into muscles and joints bleeding after trauma may be delayed and is prolonged frequently restarts after stopping
27
How is bleeding due to platelet and coagulation defects clinically distinguished
Platelet - superficial bleeding into skin, mucosal membranes. Immediate after injury Coagulation- bleeding into deep tissue, muscle and joints, delayed but severe and prolonged bleeding
28
What are the tests for coagulation disorders
Screening tests (clotting screen) Prothrombin time (PT) Activated partial thromboplastin time (APTT) Full blood count (platelets) Factor assays (for Factor VIII etc) Tests for inhibitors
29
Which bleeding disorders are not detected by routine clotting tests
``` Mild factor deficiencies von Willebrand disease Factor XIII deficiency (cross linking) Platelet disorders Excessive fibrinolysis Vessel wall disorders Metabolic disorders (e.g. uraemia) (Thrombotic disorders) ```
30
What are some causes of fibrinolysis disorders
hereditary - antiplasmin deficiency Acquired - drugs (tPA), disseminated intravascular coagulation
31
Describe the genetics of von willebrand disease
Autosomal dominant Type 2 = AD type 3 = AR
32
Describe the genetics of most bleeding disorders
Autosomal recessive
33
What is the treatment for abnormal haemostasis from failure of production/function
Replace missing factor/platelets - Prophylactic - Therapeutic Stop drugs
34
What is the treatment for abnormal haemostasis from immune destruction
What is the treatment for abnormal haemostasis from failure of production/function
35
What is the treatment for abnormal haemostasis from increased consumption
Treat cause | Replace as necessary
36
What can be used in factor replacement therapy
Plasma Cryoprecipitate Factor concentrates Recombinant forms of FVIII and FIX
37
Describe plasma and cryoprecipitate for replacement therapy
Plasma = contains all coagulation factors Cryoprecipitate = rich in fibrinogen, FVIII, VWF, FXIII
38
Describe factor concentrates
Concentrates available for all factors except factor V. | Prothrombin complex concentrates (PCCs) Factors II, VII, IX, X
39
What are the the principle treatments of Haemostatic | Disorders Causing Bleeding
Factor replacement therapy Gene therapy (haemophilia) Platelet replacement therapy
40
What are some additional haemostat treatments
DDAVP Tranexamic acid Fibrin glue/spray
41
Describe DDAVP
Desmopressin Vasopressin derivative 2-5 fold rise in VWF-VIII (VIII>vWF) Releases endogenous stores - Hence only useful in mild disorders
42
Describe transexamic acid
Inhibits fibrinolysis Widely distributed – crosses placenta Low concentration in breast milk